| 臺大學術典藏 |
2021-03-18T08:54:05Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Wu J.-R.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:02Z |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang C.-E.; Ueng K.-C.; Chao T.-H.; Lin T.-H.; Wu Y.-J.; Wang K.-L.; Sung S.-H.; Yeh H.-I.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Shyu K.-G.; Huang J.-L.; Tsai C.-D.; Hung H.-F.; Liu M.-E.; Chao T.-F.; Cheng S.-M.; Cheng H.-M.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Chen W.-J.; Lai W.-T.; Lin S.-J.; Yeh S.-J.; Hwang J.-J. |
| 臺大學術典藏 |
2021-03-18T08:54:01Z |
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease
|
YEN-WEN WU; Ho S.K.; Tseng W.-K.; Yeh H.-I.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:01Z |
Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease
|
Huang C.-C.; Chang M.-T.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Shyur L.-F.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:00Z |
Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions
|
Tsai H.-Y.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W.; Yeh H.-I.; National Taiwan Biosignature Research Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:00Z |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li Y.-H.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; YEN-WEN WU; Hsieh I.-C.; Lin T.-H.; Sheu W.H.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 國立成功大學 |
2021 |
Fasting triglycerides is a risk factor for cardiovascular event in T-SPARCLE registry in Taiwan
|
Chen, Chen C.-Y.;Tseng, W.-K.;Lin, F.-J.;Wu, Y.-W.;Lin, T.-H.;Li, Y.-H.;Sheu, W.H.-H.;Huang, L.-C.;Hsieh, I.C.;Pan, W.-H.;Yeh, H.I.;Wu, C.-C.;Yin, W.-H.;Chen, J.-W. |
| 國立成功大學 |
2021 |
2021 Consensus Pathway of the Taiwan Society of Cardiology on Novel Therapy for Type 2 Diabetes
|
Chiang, Chiang C.-E.;Ueng, K.-C.;Chao, T.-H.;Lin, T.-H.;Wu, Y.-J.;Wang, K.-L.;Sung, Sung S.-H.;Yeh, H.-I.;Li, Y.-H.;Liu, P.-Y.;Chang, K.-C.;Shyu, K.-G.;Huang, J.-L.;Tsai, C.-D.;Hung, Hung H.-F.;Liu, M.-E.;Chao, T.-F.;Cheng, S.-M.;Cheng, H.-M.;Chu, P.-H.;Yin, W.-H.;Wu, Y.-W.;Chen, W.-J.;Lai, W.-T.;Lin, S.-J.;Yeh, S.-J.;Hwang, J.-J.;Hou, C.J.-Y. |
| 臺大學術典藏 |
2020-12-30T08:47:37Z |
2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
|
Wen M.-S.; Cheng C.-C.; Chen Y.-J.; Chen M.-C.; Wang K.-L.; Lin L.-Y.; Chiang C.-E.; Wu T.-J.; Ueng K.-C.; Chao T.-F.; Chang K.-C.; Wang C.-C.; Lin Y.-J.; Yin W.-H.; Kuo J.-Y.; Lin W.-S.; CHIA-TI TSAI; Liu Y.-B.; Lee K.-T.; Lin L.-J.; Chen W.-J.; Chen J.-H.; Lai W.-T.; Chiou C.-W.; Lin J.-L.; Yeh S.-J.; Chen S.-A. |
| 臺大學術典藏 |
2020-12-30T08:47:34Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L.; Chiang C.-E.; Lin S.-Y.; Lin T.-H.; Wang T.-D.; Yeh H.-I.; Chen J.-F.; CHIA-TI TSAI; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chao T.-H.; Shyu K.-G.; Yang W.-S.; Ueng K.-C.; Chu P.-H.; Yin W.-H.; Wu Y.-W.; Cheng H.-M.; Shin S.-J.; Huang C.-N. |
